Virax Biolabs Group Ltd (VRAX)
1.35
+0.03
(+2.27%)
USD |
NASDAQ |
Jun 25, 16:00
1.35
0.00 (0.00%)
After-Hours: 20:00
Virax Biolabs Group Total Assets (Quarterly): 7.025M for Sept. 30, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 7.025M |
| September 30, 2023 | 7.025M |
| March 31, 2023 | 9.812M |
| September 30, 2022 | 5.299M |
| September 30, 2022 | 5.299M |
| Date | Value |
|---|---|
| March 31, 2022 | 0.0487M |
| September 30, 2021 | 0.043M |
| September 30, 2021 | 0.043M |
| March 31, 2021 | 0.0396M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
0.0396M
Minimum
Mar 2021
9.812M
Maximum
Mar 2023
3.848M
Average
5.299M
Median
Sep 2022
Total Assets (Quarterly) Benchmarks
| Barinthus Biotherapeutics PLC | 199.48M |
| Adaptimmune Therapeutics PLC | 258.01M |
| Biodexa Pharmaceuticals Plc | 13.43M |
| Verona Pharma PLC | 289.91M |
| NuCana PLC | 31.31M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 0.919M |
| Shareholders Equity (Quarterly) | 6.333M |
| Current Ratio | 7.587 |